Your browser doesn't support javascript.
loading
COVID-19 Vaccination Rates in a Global HIV Cohort.
Fulda, Evelynne S; Fitch, Kathleen V; Overton, Edgar T; Zanni, Markella V; Aberg, Judith A; Currier, Judith S; Lu, Michael T; Malvestutto, Carlos; Fichtenbaum, Carl J; Martinez, Esteban; Umbleja, Triin; Douglas, Pamela S; Ribaudo, Heather J; Grinspoon, Steven K.
Afiliação
  • Fulda ES; Metabolism Unit, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Fitch KV; Metabolism Unit, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Overton ET; Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Zanni MV; Metabolism Unit, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Aberg JA; Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Currier JS; Division of Infectious Diseases, University of California at Los Angeles, Los Angeles, California, USA.
  • Lu MT; Cardiovascular Imaging Research Center, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Malvestutto C; Division of Infectious Diseases, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
  • Fichtenbaum CJ; Department of Medicine for Translational Research, University of Cincinnati, Cincinnati, Ohio, USA.
  • Martinez E; Hospital Clinic and University of Barcelona, Barcelona, Spain.
  • Umbleja T; Center for Biostatistics in AIDS Research, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA.
  • Douglas PS; Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina, USA.
  • Ribaudo HJ; Center for Biostatistics in AIDS Research, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA.
  • Grinspoon SK; Metabolism Unit, Massachusetts General Hospital, Boston, Massachusetts, USA.
J Infect Dis ; 225(4): 603-607, 2022 02 15.
Article em En | MEDLINE | ID: mdl-34794178
ABSTRACT
Little is known regarding coronavirus disease 2019 (COVID-19) vaccination rates in people with HIV (PWH), a vulnerable population with significant morbidity from COVID-19. We assessed COVID-19 vaccination rates among 6952 PWH in the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE) compared to region- and country-specific vaccination data. The global probability of COVID-19 vaccination through end of July 2021 was 55% among REPRIEVE participants with rates varying substantially by Global Burden of Disease (GBD) superregion. Among PWH, factors associated with COVID-19 vaccination included residence in high-income regions, age, white race, male sex, body mass index, and higher cardiovascular risk. Clinical Trials Registration. NCT02344290.
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / Vacinação / Vacinas contra COVID-19 / COVID-19 Tipo de estudo: Clinical_trials / Risk_factors_studies Limite: Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / Vacinação / Vacinas contra COVID-19 / COVID-19 Tipo de estudo: Clinical_trials / Risk_factors_studies Limite: Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article